Nasus Pharma NSRX
NYSE NSRX
$2.91 -0.02 (-0.87%)
As of: Nov 10, 2026 · 1:28 PM EST

Nasus Pharma (NSRX) Total Current Liabilities (2024 - 2026)

Updated

Nasus Pharma (NSRX) reported Total Current Liabilities of $1.4 million for Q2 2026, down 71.7% from $4.95 million a year earlier.

Analysis

Nasus Pharma (NSRX) Total Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma posted Total Current Liabilities of $2.16 million, down 44.9% from FY2024.

  • By year, Total Current Liabilities came in at $3.93 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 55.46 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 43.10 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 31.55 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 12.00 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 31.73 Bn
10 Nasus Pharma 23.71 Mn 23.71 Mn - 2.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.40 Mn
Dec 31, 2025 2.16 Mn
Jun 30, 2025 4.95 Mn
Dec 31, 2024 3.93 Mn
API Access

Nasus Pharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NSRX&period=max&api_key=YOUR_API_KEY